The ins and outs of SARS-CoV-2 variants of concern (VOCs)

被引:35
作者
Salehi-Vaziri, Mostafa [1 ,2 ,3 ]
Fazlalipour, Mehdi [1 ]
Seyed Khorrami, Seyed Mahmood [4 ]
Azadmanesh, Kayhan [3 ,5 ]
Pouriayevali, Mohammad Hassan [1 ,2 ]
Jalali, Tahmineh [1 ,2 ]
Shoja, Zabihollah [5 ]
Maleki, Ali [1 ,5 ]
机构
[1] Pasteur Inst Iran, COVID Natl Reference Lab 19, 69 Pasteur Ave, Tehran 1316943551, Iran
[2] Pasteur Inst Iran, Dept Arboviruses & Viral Hemorrhag Fevers, Natl Reference Lab, Tehran, Iran
[3] Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Tehran, Iran
[4] Tarbiat Modares Univ, Dept Virol, Fac Med Sci, Tehran, Iran
[5] Pasteur Inst Iran, Dept Mol Virol, Tehran, Iran
关键词
RECEPTOR-BINDING DOMAIN; MUTATIONS; COVID-19; B.1.1.7; RISK; VACCINE;
D O I
10.1007/s00705-022-05365-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
SARS-CoV-2, a newly emerging coronavirus that caused the COVID-19 epidemic, has been spreading quickly throughout the world. Despite immunization and some fairly effective therapeutic regimens, SARS-CoV-2 has been ravaging patients, health workers, and the economy. SARS-CoV-2 mutates and evolves to adapt to its host as a result of extreme selection pressure. As a consequence, new SARS-CoV-2 variants have emerged, some of which are classified as variants of concern (VOC) because they exhibit greater transmissibility, cause more-severe disease, are better able to escape immunity, or cause higher mortality than the original Wuhan strain. Here, we introduce these VOCs and review their characteristics, such as transmissibility, immune escape, mortality risk, and diagnostics.
引用
收藏
页码:327 / 344
页数:18
相关论文
共 146 条
  • [71] Landis J, 2021, INTRAHOST EVOLUTION
  • [72] Lefevre B, 2021, IMPACT B 1 351 BETA, DOI [10.1101/2021.07.28.21261285, DOI 10.1101/2021.07.28.21261285]
  • [73] Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020
    Leung, Kathy
    Shum, Marcus H. H.
    Leung, Gabriel M.
    Lam, Tommy T. Y.
    Wu, Joseph T.
    [J]. EUROSURVEILLANCE, 2021, 26 (01) : 15 - 21
  • [74] Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
    Levin, Andrew T.
    Hanage, William P.
    Owusu-Boaitey, Nana
    Cochran, Kensington B.
    Walsh, Seamus P.
    Meyerowitz-Katz, Gideon
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2020, 35 (12) : 1123 - 1138
  • [75] Liu Yang, 2021, bioRxiv, DOI 10.1101/2021.03.08.434499
  • [76] Covid-19: Sore throat, fatigue, and myalgia are more common with new UK variant
    Mahase, Elisabeth
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 372 : n288
  • [77] Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein
    Makowski, Lee
    Olson-Sidford, William
    Weisel, John W.
    [J]. VIRUSES-BASEL, 2021, 13 (02):
  • [78] SARS-CoV-2 Viral Variants-Tackling a Moving Target
    Mascola, John R.
    Graham, Barney S.
    Fauci, Anthony S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (13): : 1261 - 1262
  • [79] Current Status of Putative Animal Sources of SARS-CoV-2 Infection in Humans: Wildlife, Domestic Animals and Pets
    Maurin, Max
    Fenollar, Florence
    Mediannikov, Oleg
    Davoust, Bernard
    Devaux, Christian
    Raoult, Didier
    [J]. MICROORGANISMS, 2021, 9 (04)
  • [80] McCallum Matthew, 2021, bioRxiv, DOI 10.1101/2021.03.31.437925